Page last updated: 2024-10-29

ketanserin and Muscular Dystrophy, Animal

ketanserin has been researched along with Muscular Dystrophy, Animal in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Muscular Dystrophy, Animal: MUSCULAR DYSTROPHY that occurs in VERTEBRATE animals.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Howlett, SE1
Triggle, CR1
Hoekman, TB1

Other Studies

1 other study available for ketanserin and Muscular Dystrophy, Animal

ArticleYear
Effects of noradrenaline, serotonin, and selected antagonists on the vascular smooth muscle of normal and dystrophic chickens.
    Canadian journal of physiology and pharmacology, 1986, Volume: 64, Issue:5

    Topics: Animals; Chickens; Dose-Response Relationship, Drug; Ketanserin; Male; Muscle Contraction; Muscle, S

1986